What's Happening?
Reps. Greg Murphy, M.D. (R-N.C.) and Brad Schneider (D-Ill.), both members of the House Ways and Means Committee, have introduced the bipartisan Access to Medical Supplies Act (H.R. 10787). This bill aims to pause the inclusion of ostomy and urological
supplies in Medicare’s competitive bidding program for durable medical equipment, prosthetics, orthotics, and supplies for a period of five years. During this five-year pause, the legislation mandates the establishment of a technical expert panel to assess the suitability of these products for competitive bidding and to recommend methods for protecting patient access if they are included. Additionally, it requires a demonstration project to evaluate the effects on patients before the Centers for Medicare & Medicaid Services (CMS) makes a final decision. AdvaMed, a medical technology association, supports this bill, emphasizing that ostomy and urological supplies are highly personalized and essential for approximately one million Americans, making them distinct from standardized items typically suited for competitive bidding.
Why It's Important?
The proposed legislation is crucial for ensuring continued access to essential medical supplies for a significant portion of the U.S. population. Ostomy and urological supplies are vital for individuals with conditions resulting from birth defects, injury, trauma, or cancer, which affect bowel and bladder function. The highly personalized nature of these products, requiring in-person fittings and hands-on training, means that a poor fit can lead to severe health complications like leakage, skin breakdown, infection, and hospitalization. Medicare's competitive bidding program, designed to lower prices for standardized items, could significantly reduce the number of suppliers for these specialized products, potentially jeopardizing patient access, especially for seniors in rural areas. This bill seeks to prevent such an outcome by allowing for a thorough evaluation of the impact on patients before any changes are implemented, thereby safeguarding the quality of life and health outcomes for vulnerable patients.
What's Next?
The Access to Medical Supplies Act (H.R. 10787) will proceed through the legislative process in Congress. AdvaMed has stated its commitment to continue working with Congress, CMS, and patient and clinician organizations to advocate for the bill's passage. The goal is to ensure that Medicare's cost-saving initiatives do not compromise patient access to essential medical supplies. If passed, the bill would initiate a five-year period of study and demonstration projects, during which a technical expert panel would provide recommendations to CMS. The outcome of these studies and projects will ultimately determine the future of how ostomy and urological supplies are handled within Medicare's competitive bidding program, with a focus on balancing cost efficiency with patient well-being.
Beyond the Headlines
This legislative effort highlights a broader tension within healthcare policy: balancing cost containment with the provision of high-quality, patient-centered care. While competitive bidding programs are often implemented to reduce healthcare expenditures, their application to highly specialized and personalized medical devices like ostomy and urological supplies raises ethical and practical concerns. The bill implicitly acknowledges that not all medical products can be treated as commodities, and that for certain items, patient-specific needs and the expertise of suppliers are paramount. This situation could set a precedent for how other specialized medical technologies are evaluated for inclusion in cost-saving programs, potentially influencing future policy decisions regarding patient access and the role of personalized care in the U.S. healthcare system.













